Shi, Jinming
Li, Ning
Tang, Yuan
Jiang, Liming
Yang, Lin
Wang, Shulian
Song, Yongwen
Liu, Yueping
Fang, Hui
Lu, Ningning
Qi, Shunan
Chen, Bo
Li, Ziyu
Liu, Shixin
Wang, Jun
Wang, Wenling
Zhu, Suyu
Yang, Jialin
Li, Yexiong
Zhao, Dongbing
Jin, Jing
Clinical trials referenced in this document:
Documents that mention this clinical trial
Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
https://doi.org/10.1186/s12876-022-02440-5
A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma
https://doi.org/10.1038/s41598-024-58177-6
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (No.LC2018L03)
Article History
Received: 18 May 2022
Accepted: 20 July 2022
First Online: 28 July 2022
Declarations
:
: Institutional review board approval was obtained for this trial from the ethical committee of the Chinese Academy of Medical Sciences. The trial is published on ClinicalTrials.gov (number: NCT04062058, ExternalRef removed). Written informed consent is obtained from all participants.
: Not applicable.
: The authors have declared that no competing interests exist.